Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000187062 | SCV000224521 | likely benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000187062 | SCV000240637 | likely benign | not specified | 2017-11-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Pediatric Genomic Medicine, |
RCV000429471 | SCV000511529 | likely benign | not provided | 2016-12-05 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000989147 | SCV000560158 | benign | Neuronal ceroid lipofuscinosis | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000429471 | SCV000612844 | benign | not provided | 2018-11-05 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000671703 | SCV000796704 | likely benign | Neuronal ceroid lipofuscinosis 5 | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313021 | SCV000848986 | likely benign | Inborn genetic diseases | 2018-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000429471 | SCV000892070 | benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | CLN5: BS1, BS2 |
Mendelics | RCV000989147 | SCV001139363 | likely benign | Neuronal ceroid lipofuscinosis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000671703 | SCV001460312 | benign | Neuronal ceroid lipofuscinosis 5 | 2020-04-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003975257 | SCV004794030 | likely benign | CLN5-related disorder | 2019-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |